abstract |
The present invention relates to a new use of ginsenoside M1 for treatment in particular cancer, including melanoma and prostate cancer. Specifically, the present invention relates to ginsenoside M1 for use in inhibiting growth and suppressing, reducing, blocking and/or preventing tumor metastasis of melanoma cells and prostate cancer cells. |